UBS Reinstates Buy on IQVIA Holdings, Announces $345 Price Target
9/30/2026
Impact: 85
Healthcare
UBS analyst Kevin Caliendo has reinstated a Buy rating on IQVIA Holdings (NYSE: IQV) and set a price target of $345 for the stock. This recommendation may influence investor sentiment and trading activity for IQVIA in the market.
AI summary, not financial advice
Share: